Distribution of c-Fos in guinea-pig brain following morphine withdrawal

Brain Research

Volumn 717, Issue 1-2, 1996, Pages 127-134

  Chahl, L A ^a   Leah, J ^b   Herdegen, T ^c   Trueman, L ^b   Lynch Frame, A M ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

brain; c Fos; guina pig; morphine; naltrexone; opioid; withdrawal

Indexed keywords

MORPHINE; NALOXONE; NALTREXONE; OPIATE ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; GENE EXPRESSION; GUINEA PIG; IMMEDIATE EARLY GENE; IMMUNOCYTOCHEMISTRY; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029882018     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00041-8     Document Type: Article

References (26)

1. Abbadie, C. and Besson, J.-M., Effects of morphine and naloxone on basal and evoked Fos-like immunoreactivity in lumbar spinal cord neurons of arthritic rats, Pain, 52 (1993) 29-39.
2. Bandler, R.P. and Shipley, M.T., Columnar organisation in the midbrain peri-aqueductal gray: modules for emotional expression?, Trends Neurosci., 17 (1994) 379-389.
3. Bot, G. and Chahl, L.A., Brent, P.J. and Johnston, P.A., Effects of intracerebroventricularly administered mu-, delta- and kappa-opioid agonists on locomotor activity of the guinea-pig and the pharmacology of the locomotor response to U50,488H, Neurophannacology, 31 (1992) 825-833.
4. Brent, P.J., Johnston, P.A. and Chahl, L.A., Increased plasma catecholamines and locomotor activity induced by centrally administered substance P in guinea-pigs, Neuropharmacology, 27 (1988) 743-748.
5. Chahl, L.A., Capsaicin pretreatment does not inhibit the opioid withdrawal response in guinea-pigs. Eur. J. Pharmacol., 158 (1988) 91-98.
6. Chahl, L.A. and Thornton, C.A., Locomotor activity and contracture of isolated ileum precipitated by naloxone following treatment of guinea-pigs with a single dose of morphine, J. Pharm. Pharmacol., 39 (1987) 52-54.
7. Chang, S.L. and Harlan, R.E., The fos proto-oncogene protein: regulation by morphine in the rat hypothalamus, Life Sci., 46 (1990) 1825-1832.
8. Chang, S.L., Kenigs, V., Moldow, R.L. and Zadina, J.E., Chronic treatment with morphine and ethanol, but not cocaine, attenuates IL-1β activation of Fos expression in the rat hypothalamic paraventricular nucleus. In B. Sharp et al. (Eds.), The Brain Immune Axis and Substance Abuse, Plenum Press, New York, 1995, pp. 201-208.
9. Chang, S.L., Squinto, S.O. and Harlan, R.E., Morphine activation of c-fos expression in rat brain, Biochem. Biophys. Res. Commun., 157 (1988) 698-704.
10. Chang, S.L., Zardina, J.E., Spriggs, L. and Squinto, S.P., Prolonged activation of c-fos and optimal activation of pro-opiomelanocortin mRNA after repeated morphine exposure in SH0SY5Y cells, Mol. Cell. Neurosci., 4 (1993) 25-29.
11. Chieng, B., Keay, K.A. and Christie, M.J., Increased fos-like immunoreactivity in the periaqueductal gray of anaesthetised rats during opiate withdrawal, Neurosci Lett., 183 (1995) 79-82.
12. Crain, S.M. and Shen, K.F., Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons, Trends Pharmacol. Sci., 11 (1990) 77-81.
13. Geary, W.A. and Woolen, G.F., A behavioural and 2-deoxyglucose autoradiographic study of the effects of cumulative morphine dose on precipitated withdrawal in the rat, Brain Res., 275 (1983) 117-126.
14. Geary, W.A. and Wooten, G.F., Time action profiles of regional cerebral glucose utilization during naloxone-precipitated morphine withdrawal, Brain Res., 399 (1986) 181-184.
15. Hayward, M.D., Duman, R.S. and Nestler, E.J., Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of rat brain, Brain Res., 525 (1990) 256-266.
16. Hope, B., Kosofsky, B., Hyman, S.E. and Nestler, E.J., Regulation of immediate early gene expression and AP-I binding in the rat nucleus accumbens by chronic cocaine, Proc. Natl. Acad. Sci. USA, 79 (1992) 5764-5768.
17. Hunt, S.P., Pini, A. and Evan, G., Induction of c-fos-like protein in spinal cord neurons following sensory stimulation, Nature, 328 (1987) 632-634.
18. Johnston, P.A. and Chahl, L.A., Tachykinin antagonists inhibit the morphine withdrawal response in guinea-pigs, Naunyn-Schmiedeberg's Arch. Pharmacol., 343 (1991) 283-288.
19. Leah, J.D., Herdegen, T. and Bravo, R., Selective expression of Jun proteins following axotomy and axonal transport block in peripheral nerves in the rat: evidence for a role in the regeneration process, Brain Res., 566 (1991) 198-207.
20. Liu, J., Nickolenko, J. and Sharp, F.R., Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors, Proc. Natl. Acad. Sci. USA, 91 (1994) 8537-8541.
21. Mansour, A., Khachaturian, H., Lewis, M.E., Akil, H. and Watson, S.J., Anatomy of CNS opioid receptors, Trends Neurosci., 11 (1988) 308-314.
22. Morgan, J.I. and Curran, T., Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun, Annu. Rev. Neurosci., 14 (1991) 421-451.
23. Nestler, E.J., Hope, B.T. and Widnell, K., Drug addiction: a model for the molecular basis of neural plasticity. Neuron, 11 (1993) 995-1006.
24. Unterwald, E.M. and Kornetsky, C., Reinforcing effects of opiates -modulation by dopamine. In R.P. Hammer (Ed.), Neurobiology of Opiates, CRC Press, Boca Raton, 1993, pp. 361-391.
25. Wooten, G.F., Functional anatomy of opiate withdrawal. In R.P. Hammer (Ed.). Neurobiology of Opiates, CRC Press, Boca Raton, 1993, pp. 165-174.
26. Zieglgänsberger, W., French, E.D., Siggins, G.R. and Bloom, F.E., Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons. Science, 205 (1979) 415-417.